TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
On May 7, 2026, TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a company specializing in soft-tissue reconstruction solutions, disclosed that the Compensation Committee of its Board of Directors authorized the allocation of inducement grants. These grants consist of restricted stock units, encompassing 89,250 shares of TELA Bio's common stock, allocated to 12 newly recruited employees. The grant was effective on May 5, 2026. This allocation was made under the Nasdaq Rule 5635(c)(4) inducement grant exception to serve as part of each individual's employment package and as an incentive for joining TELA Bio.
Source: Unusual Whales The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments